Status:
UNKNOWN
Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol
Lead Sponsor:
Sarah Abdelbar Mahmoud
Conditions:
Caries
Eligibility:
All Genders
4-6 years
Phase:
PHASE3
Brief Summary
examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.
Detailed Description
Primary outcome: Soft-tissue pathology * Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be ass...
Eligibility Criteria
Inclusion
- Medically fit and cooperative children.
- Pediatric patients aged 4-6 years.
- A deep carious lesion in vital primary molars.
- Absence of clinical signs and symptoms of pulpal exposure.
- Absence of radiographic signs and symptoms of people degeneration.
- Positive parental informed consent.
Exclusion
- Uncooperative children.
- Medically compromised children.
- Presence of clinical signs and symptoms of pulpal exposure.
- Presence of radiographic signs and symptoms of pulp degeneration.
- Physiologic root resorption more than one-third.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05314842
Start Date
April 1 2022
End Date
May 1 2023
Last Update
April 6 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.